|
|
 |
Reply
| | | From: GreedyScott (Original Message) | Sent: 6/15/2007 11:15 PM |
Hey Kutz... Since you are working late anyway... lol... Cramer is pumping this as a double possibility... says it has good cardio drugs... One approved, and another potentially on the way... also called it a potential take-over target... Price was around $11.30 when he started blabbing about it... Approved: Ranexa (ranolazine extended-release tablets), which was approved in the United States, in January 2006, for the treatment of chronic angina... Pending: Regadenoson, a selective A2A-adenosine receptor agonist, for use as a pharmacologic agent in myocardial perfusion imaging studies. (Huh? Does this mean taking pictures of the heart?... Lol... ) |
|
Reply
| | | From: Kutz | Sent: 4/15/2008 10:22 PM |
Trading halted on CVTX. Announce at market close of a licensing aggreement for newly approved imaging agent Lexiscan (Regadensen). The aggreement calls for a payment of 185 million dollars for 50% of North American rights. Have never heard of the collaborator. This is a pretty good piece of change to allow for continued development of their lead compound already approved for one indication (Ranexa). There was no pop on approval, but I bet its going to get a pop on this news! Kutz  |
|
Reply
| | | From: Kutz | Sent: 4/15/2008 11:44 PM |
Trading back on-up 25% in AH. This one may be a wild ride tomorrow? Kutz  |
|
Reply
| | | From: Kutz | Sent: 4/24/2008 8:18 PM |
Now I am going in my pants! did not see it initially but see the same document linked in the PGNX post. CVTX got a positive reccomendation for approval of their drug in the EU. Here is another link------LOL! Yeeehaw! Kutz |
|
Reply
| | | From: Kutz | Sent: 6/17/2008 2:28 PM |
Finally getting to be crunch time here for this bio ticker on the regulatory front. cramer said this was a buyout candidate last year-so much for him! There will be no less than 3 FDA decisions coming on different cardio-type conditions for Ranexa and another coming out of the EU. All in the next 1-6 weeks! If all were a success, this company would finally fly. Will it happen-I don't know, but I have some shares! Long wait here for me-longer than I wanted-hope to gain and place the money elsewhere! Currently underwater but can be made up with some positive decisions easily. Kutz  |
|
Reply
| | | From: Kutz | Sent: 6/17/2008 3:05 PM |
Doubled up on CVTX-it lowers my average-nothing to do but wait. Kutz |
|
Reply
| | | From: Kutz | Sent: 7/11/2008 12:22 AM |
Another approval here!  This time it is EU approval for Ranexa for chronic angina. Announced AH! They will begin pricing negotiations with all 27 members and hope to sell in Europe next year. EU patients use these drugs more than US patients. Its already approved and selling in the US. They are also trying to get approval for other sub-cardio indications that are pending. This company also recently got approval for Lexiscan-a contrast agent and did a big collaboration. I doubled up a little while back and posted. It really would be nice to see appeciable movement in this PPS based on all this news? Its up 6.58% in AH on really light volume-a surprise to the market? AND YES! Greedy this is that stock you asked me about  and Cramer  said was going to be bought out over a year ago-I'm still in and Cramer is still a clown!  Will persistence pay off? Kutz  |
|
Reply
| | | From: Kutz | Sent: 7/28/2008 3:07 PM |
The FDA strikes again-they ain't ready! No shit! Who wants this independent to vote for McCain? They are costing me money daily and its not very capitalistic in nature!! Democrats are socialists/communists and Republicans are fascists! Why argue about which is worse-they both are bottom feeders! Greedy for president!  I say dump the FDA, save some money, and sell drug elixors out of the back of covered wagons!---LOLOL Kutz |
|
Reply
| | | From: Kutz | Sent: 7/28/2008 3:21 PM |
Post 60: Bought then ("doubled up")-now I am flipping shares-made a little green! keep the original investment thats still under water! If they don't want to decide, guess there is no reason to have an expanded position. raising cash for later moves! There is always another time and place! Kutz |
|
Reply
| | | From: Kutz | Sent: 8/5/2008 6:33 PM |
Ticker at an 8-month high but mine are still underwater. Tells you how long I have been holding onto this Cramer pumped pig! At least its making progress toward profitabliity. Could be going down! I am going to squeeze a profit out of this yet! Maybe when fianlly successful it will have long term capital gains consequences?  Kutz |
|
Reply
| | | From: Kutz | Sent: 8/15/2008 1:39 AM |
CVTX: $10.60; +$0.48; +4.74%; Ranexa (goes by another name in Europe)approved in EU (about 30 countries.). Increases the chances the FDA will approve for one or more indications submitted (3 different ones). Getting to break even! Long haul because of Cramer! Kutz |
|
Reply
| | | From: Kutz | Sent: 8/28/2008 2:37 PM |
CVTX now at $11.34 been slowly an steasdily climbing for a good three months now! We will see? Kutz |
|
Reply
| | | From: Kutz | Sent: 11/6/2008 12:31 PM |
CVTX received their FDA approval and line extentions for Ranexa and was PR'd early this AM. This is good news for patients with angina and allows CVTX to sell this on expanded levels and therfore increase its profit! Been a long haul for this ticker since Greedy presented it almost 16 months ago and Cramer was pumping it. Kutz has been holding onto shares throughout. I watch what this PPS will do on this great news and yet still within the noise of a bad market overall. Therefore who knows how it will react? Some say this company will get bought out with the news today? My time with this ticker is about done no matter where the momentum goes here. Depending on what happens, its almost time to move my money to another entity. Kutz |
|
Reply
| | | From: Kutz | Sent: 11/7/2008 3:18 PM |
Just amazing-its PPS is lower than before approval! Ranexa is now available to at least 1 million more patients and its down and the drug isn't cheap? This market is more dysfunctional than the folks on that show "The Nanny" hell you don't even want good news to come out in this market mess! Between 20-25% shares short here. Might be driving it down to cover? This is what happens when you have great news but suspect visability, and it has implications for ACUS Al!? I hold, but no sense buying-this might get dragged into the basement before it pretends to go where it should! Kutz |
|
Reply
| | | From: Kutz | Sent: 11/10/2008 3:16 PM |
Added a little here soon after the open!. Still thinking I want more, but hedging and wanting to watch it more before moving again! Most biotech doing well this AM. Credit loosing slowly over time helps! Kutz |
|
Reply
| | | From: Kutz | Sent: 12/16/2008 10:07 AM |
For biotech educational purposes! Came across this graph of CVTX. It charts the ratching up of Ranexa sales for CVTX vs their PPS price over about 2 years. It also adds in the significant news events that have occurred for CVTX during the time period. These events include data presentation to the public as they become available across the sales axis, FDA approvals, partnerships, and milestone payments off those partnerships. This PPS activity versus the good stuff happening at this company is exactly what is wrong with biotech investing today! Not only do you have to negotiate the intrinsic toughness of anticipating and doing due diligence on these PR timepoints, you now have to evaluate the capability of hedgefunds to short these stocks with their power, the fallout when hedgefunds explode and redemptions come due, the credit crunch, economic maliase, and the FDA! A similar chart can be drawn for BMRN pr PGNX! CVTX and PGNX should be at $20.00-25.00 and BMRN should be at least $40.00 using metrics from 5 years ago. They are not! good fundamental and technical analysis does not assure profit when playing these anymore. The marketplace itself has taken a tough markket space to play and turned it into a joke! Good is bad-bad s good-sometimes it just doesn't matter! This is what we get for polluting our marketplace with all we have seen eminating from it for several years Thats alot of shit to negotiate and a shithole for retailers to play for profit! Kutz |
|
|
|
Free Forum Hosting
Important Announcement
Recommend
Return to General